Product Information
AMLODIPINE-OLMESARTAN 10-20 MG is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.2477 per EA under NDC 62332021490. Its NADAC has been published 117 times since Jul 10, 2024.
FDA first approved this application on Jul 17, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10; 20 mg/1; mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332021490
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA207073FDA Approved
7/17/2017
TE Code
AB
On Market Since
7/18/2017
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-OLMESARTAN 10-20 MG has been published 117 times since Jul 10, 2024, and over the history we have for it it has declined 29.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2477 per EA |
|---|---|
| All-time high | $0.4546 (Nov 13, 2024) |
| All-time low | $0.2298 (Aug 19, 2026) |
| 52-week high | $0.3460 |
| 52-week low | $0.2298 |
| Median price | $0.3265 |
| Average price | $0.3242 |
| Largest weekly change | -41.1% (Nov 20, 2024) |
| Weeks tracked | 117 |
| Tracking since | Jul 10, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amlodipine besylate and Olmesartran medoxomil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMLODIPINE-OLMESARTAN 10-20 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 10-20 MG, manufactured by Alembic Pharmaceuticals Inc., is $0.2477 per EA (NDC 62332021490), effective Sep 30, 2026.
How has the price of AMLODIPINE-OLMESARTAN 10-20 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 10-20 MG has declined 29.5%. It has been tracked across 117 weekly CMS publications since Jul 10, 2024.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 10-20 MG?
Since Jul 10, 2024, the NADAC for AMLODIPINE-OLMESARTAN 10-20 MG has ranged from a low of $0.2298 (Aug 19, 2026) to a high of $0.4546 (Nov 13, 2024), with a median of $0.3265 per EA.
Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 10-20 MG?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-OLMESARTAN 10-20 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures AMLODIPINE-OLMESARTAN 10-20 MG?
AMLODIPINE-OLMESARTAN 10-20 MG (NDC 62332021490) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.